Amarin (AMRN) has been issued a patent by the USPTO covering the pharmaceutical composition of...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Amarin (AMRN) has been issued a patent by the USPTO covering the pharmaceutical composition of the company's Vascepa capsules. Vascepa has already been approved by the FDA for the treatment of high levels of triglycerides, and the company plans to list the patent in the FDA's Orange Book.